Planned CORR: Planned Care for Obesity and Risk Reduction
Planned CORR
2 other identifiers
interventional
262
1 country
1
Brief Summary
The researchers propose a randomized controlled trial to evaluate how well an intervention, Planned Care for Obesity \& Risk Reduction (Planned CORR), supports primary care treatment of obesity in adults with at least one cardiovascular risk factor (CVRF).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Nov 2009
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 10, 2010
CompletedFirst Posted
Study publicly available on registry
May 31, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedDecember 5, 2014
December 1, 2014
3.9 years
February 10, 2010
December 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary aim is to evaluate the effects at 20 months of Planned CORR on BMI when compared to enhanced usual care.
20 mo
Secondary Outcomes (3)
CVRF outcomes; physiological, metabolic, behavioral, and psychosocial factors related to obesity and CVRFs; quality of life, depression, cost-effectiveness; and medical care quality, patient, provider & staff satisfaction, and process measures.
20 mo
CVRF outcomes; physiological, metabolic, behavioral, and psychosocial factors related to obesity and CVRFs; quality of life, depression, cost-effectiveness; and medical care quality, patient, provider & staff satisfaction, and process measures.
8 months
CVRF outcomes; physiological, metabolic, behavioral, and psychosocial factors related to obesity and CVRFs; quality of life, depression, cost-effectiveness; and medical care quality, patient, provider & staff satisfaction, and process measures.
12 months
Study Arms (2)
Enhanced Usual Care
NO INTERVENTIONControl Group
Stepped Care
EXPERIMENTALIntervention
Interventions
This group receives 2 years of a stepped care intervention including provider visits, health educator sessions, phone calls and mailings and availability of self management and group sessions, text messaging and a smoker's quit line.
Eligibility Criteria
You may qualify if:
- Age: 25 - 70
- English or Spanish Speaking
- Has transportation to get to follow-up appointments
- Has a functional and stable telephone number
- Lives in San Diego, maintains a permanent address, and plans on staying in San Diego for the next 2 years
- BMI of 30-45
- Have at least ONE of the following risk factors:
- Hypertension
- Smoking
- Stabilized type II diabetes (Hemoglobin A1c Level \<8.5);
- Metabolic syndrome (defined as the presence of at least 3 of the following 5 factors: 1) elevated waist circumference: men: \> 40 inches women: \> 35 inches; 2) elevated triglycerides: \>\_150 mg/dL; 3) reduced HDL cholesterol: men \< 40 mg/dL, women \< 50 mg/dL; 4) elevated blood pressure: \>130/85 mm.Hg; 5) Elevated fasting glucose (100-125 mg/dL).
- Able to participate in moderate physical activity
You may not qualify if:
- Has not had any form of bariatric/weight loss surgery (eg, gastric bypass, lap band) \& does not intend to within 2 yrs.
- Does not have a history of substance abuse in the last 2 years (including amphetamines, opiates, and alcohol abuse) or other severe/unstable psychiatric disorder that would impair compliance with the study protocol (e.g. unstable depression, bipolar, schizophrenia).
- Is not pregnant or does not intend to become pregnant during the 2-year study period.
- Is not currently taking weight-altering medications (e.g. Sibutramine (Meridia), Orlistat (Xenical, Alli)), and has not taken them in at least 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCSD - La Jolla Professional Building
La Jolla, California, 92037-0811, United States
Related Publications (1)
Liu J, Godino JG, Norman GJ, Hill L, Calfas K, Sallis JF, Arredondo E, Rock CL, Criqui M, Zhu SH, Griffiths K, Covin J, Dillon L, Patrick K. Planned care for obesity and cardiovascular risk reduction using a stepped-down approach: A randomized-controlled trial. Prev Med. 2018 Sep;114:223-231. doi: 10.1016/j.ypmed.2018.07.015. Epub 2018 Jul 25.
PMID: 30055199DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin Patrick, MD, MS
UCSD
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 10, 2010
First Posted
May 31, 2010
Study Start
November 1, 2009
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
December 5, 2014
Record last verified: 2014-12